IgG3 donor–specific antibodies with a proinflammatory glycosylation profile may be associated with the risk of antibody-mediated rejection after kidney transplantation

Article

Abstract: The pathogenicity of de novo donor-specific antibodies (dnDSA) varies according to their characteris

Palabras claves:

alloantibody, clinical research/practice, immunobiology, kidney (allograft) function/dysfunction, kidney transplantation/nephrology, rejection: antibody-mediated (ABMR)

Autores:

Bec N., Beyze A., Bourgeois A., Champion C., Chauvin A., Christian Larroque, Couzi L., Le Quintrec M., Merville P., Mourad G., Pernin V., Perrochia H., Rene C., Szwarc I., Visentin J.

Fuentes:

scopus